GlassScriptPhysician profile
Carlos J Durham
NPI 1689674418
$4,492.06
in general payments reported to CMS, 2019-2025
15 companies · $1,313 in 2025
The $1,313 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $80.96 · 2021: $685 · 2022: $861 · 2023: $978 · 2024: $440 · 2025: $1,313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,432 · Travel and Lodging: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,432.14 |
| Travel and Lodging | $299.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,879.50 | 2019-2024 | Proclaim, Eterna, Prodigy |
| Medtronic, INC. | $1,669.76 | 2021-2025 | Synchromedii, Intellis Adaptivestim, Inceptiv |
| Boston Scientific Corporation | $277.72 | 2023 | Wavewriter Alpha Prime 16 |
| Spr Therapeutics, INC | $197.58 | 2023 | Sprint Pns System |
| Nevro Corp. | $140.12 | 2021 | |
| Medtronic USA, INC. | $84.17 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $65.59 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $37.85 | 2023 | Xtampza, Belbuca |
| Azurity Pharmaceuticals, INC. | $28.65 | 2023 | Horizant |
| Vertex Pharmaceuticals Incorporated | $27.26 | 2025 | |
| Zimmer Biomet Holdings, INC. | $20.32 | 2023 | Gel-One Cross-Linked Hyaluronate |
| Si-Bone, INC. | $18.66 | 2019 | |
| Painteq LLC | $16.38 | 2023 | Painteq |
| Curonix LLC | $15.16 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Arbor Pharmaceuticals, INC. | $13.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlos Durham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.